SCI Pharmtech Inc Net Asset Quality Index
SCI Pharmtech Inc net asset quality index. SCI Pharmtech Inc (4119) has a Net Asset Quality Index of 76.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of NT$6.93 Billion minus total liabilities of NT$1.62 Billion yields net assets of NT$5.31 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check SCI Pharmtech Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of SCI Pharmtech Inc (2002–2025)
Net asset quality index of SCI Pharmtech Inc from 2002 to 2025. This chart shows how SCI Pharmtech Inc's Net Asset Quality Index has evolved across 23 annual periods from 2002 to 2025. As of June 2026, the index stands at 76.7%, representing net assets of NT$5.31 Billion against total assets of NT$6.93 Billion TWD. See 4119 total equity for net asset value and shareholders' equity analysis.
SCI Pharmtech Inc Net Asset Quality Index by Year (2002–2025)
SCI Pharmtech Inc net asset quality index by year from 2002 to 2025. The table below presents the year-by-year Net Asset Quality Index for SCI Pharmtech Inc from 2002 to 2025, covering 23 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see SCI Pharmtech Inc market capitalisation.
| Year | Quality Index | Net Assets (TWD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 78.3% | NT$5.39 Billion | NT$6.89 Billion | NT$1.49 Billion | ▲ +2.3 pp |
| 2024 | 76.1% | NT$5.48 Billion | NT$7.20 Billion | NT$1.72 Billion | ▼ -0.2 pp |
| 2023 | 76.2% | NT$5.10 Billion | NT$6.69 Billion | NT$1.59 Billion | ▲ +3.1 pp |
| 2022 | 73.2% | NT$3.63 Billion | NT$4.96 Billion | NT$1.33 Billion | ▼ -6.1 pp |
| 2021 | 79.3% | NT$3.32 Billion | NT$4.19 Billion | NT$869.26 Million | ▲ +6.6 pp |
| 2020 | 72.7% | NT$3.32 Billion | NT$4.57 Billion | NT$1.25 Billion | ▼ -12.4 pp |
| 2019 | 85.1% | NT$3.47 Billion | NT$4.08 Billion | NT$606.84 Million | ▲ +0.4 pp |
| 2018 | 84.7% | NT$3.21 Billion | NT$3.79 Billion | NT$578.85 Million | ▼ -4.2 pp |
| 2017 | 88.9% | NT$2.93 Billion | NT$3.30 Billion | NT$365.88 Million | ▲ +2.4 pp |
| 2016 | 86.5% | NT$3.07 Billion | NT$3.55 Billion | NT$479.43 Million | ▲ +6.6 pp |
| 2015 | 79.9% | NT$2.76 Billion | NT$3.46 Billion | NT$695.02 Million | ▲ +10.8 pp |
| 2014 | 69.1% | NT$2.23 Billion | NT$3.22 Billion | NT$994.64 Million | ▲ +1.4 pp |
| 2013 | 67.7% | NT$2.07 Billion | NT$3.05 Billion | NT$984.62 Million | ▼ -12.0 pp |
| 2012 | 79.7% | NT$1.26 Billion | NT$1.58 Billion | NT$321.12 Million | ▲ +5.1 pp |
| 2011 | 74.6% | NT$1.13 Billion | NT$1.52 Billion | NT$385.26 Million | ▼ -0.6 pp |
| 2010 | 75.2% | NT$1.13 Billion | NT$1.50 Billion | NT$373.37 Million | ▼ -7.7 pp |
| 2009 | 82.9% | NT$1.04 Billion | NT$1.25 Billion | NT$214.32 Million | ▼ -0.3 pp |
| 2008 | 83.2% | NT$942.51 Million | NT$1.13 Billion | NT$190.16 Million | ▼ -0.2 pp |
| 2007 | 83.4% | NT$886.14 Million | NT$1.06 Billion | NT$176.74 Million | ▼ -5.7 pp |
| 2006 | 89.1% | NT$777.01 Million | NT$871.95 Million | NT$94.94 Million | ▲ +3.5 pp |
| 2004 | 85.6% | NT$767.10 Million | NT$896.13 Million | NT$129.03 Million | ▼ -2.3 pp |
| 2003 | 87.9% | NT$750.63 Million | NT$853.62 Million | NT$102.99 Million | ▲ +20.0 pp |
| 2002 | 67.9% | NT$546.06 Million | NT$803.82 Million | NT$257.76 Million | — |